B, B, H, & B Inc’s Pfizer PFE Stock Holding History

B, B, H, & B Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-308	Closed	-$11K	–	106
2020 Q4	$11K	Buy	+308	New	+$11.3K	0.01%	112

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

B, B, H, & B Inc's PFE Position: Q1 2021 in Review

B, B, H, & B Inc sold out of Pfizer (PFE) in Q1 2021, closing a stake of 308 shares — an estimated $11K sold.

B, B, H, & B Inc first reported a position in PFE in Q4 2020 and held it in 1 quarter. The position peaked at $11K in Q4 2020. 2,676 funds tracked by Wall St. Rank hold PFE as of Q1 2021.

B, B, H, & B Inc reported no remaining Pfizer position as of Q1 2021 after selling out during the quarter.
B, B, H, & B Inc sold 308 Pfizer shares in Q1 2021, an estimated $11K.
B, B, H, & B Inc first reported a position in Pfizer in Q4 2020 and held it in 1 quarter.
B, B, H, & B Inc's Pfizer position peaked at $11K in Q4 2020.
2,676 funds tracked by Wall St. Rank held Pfizer as of Q1 2021.

Based on B, B, H, & B Inc's 13F filing for Q1 2021, filed 11 May 2021.